Filing Details

Accession Number:
0001209191-23-046154
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-16 20:57:08
Reporting Period:
2023-08-16
Accepted Time:
2023-08-16 20:57:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1806310 Taysha Gene Therapies Inc. TSHA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1494695 B Paul Manning 200 Garrett Street, Suite S
Charlottesville VA 22902
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-16 16,466,667 $0.90 16,466,667 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 22,000 Indirect See footnote
Common Stock 2,091,704 Indirect See footnote
Common Stock 4,837,407 Indirect See footnote
Footnotes
  1. The change in the total shares held prior to the transactions reported herein reflects a change in form of ownership and, therefore, was not required to be reported pursuant to Section 16.
  2. The shares are held directly by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Revocable Trust"). The Reporting Person is the trustee of the Revocable Trust and has sole voting and investment power with respect to the shares held by the Revocable Trust.
  3. The shares are held directly by BKB G2 Investments, LLC ("BKB G2"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB G2, and has shared voting and investment power with respect to the shares held by BKB G2.
  4. The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.
  5. The shares are held directly by The PBM 2023 Grantor Retained Annuity Trust (the "Annuity Trust"). The Reporting Person is the trustee of the Annuity Trust and has sole voting and investment power with respect to the shares held by the Annuity Trust.